Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congressmen With Key Health Care Oversight Jurisdiction Named To "Super Committee"

This article was originally published in The Pink Sheet Daily

Executive Summary

Chairmen from Senate Finance and House Ways and Means and Energy and Commerce will be part of the committee tasked with finding ways to reduce federal spending.

You may also be interested in...



Beware The Debt Deal's Spending Cut Trigger: Medicare Part D And B Provider Pay Would Drop

A mandatory cut to Medicare if Congress fails to pass a joint committee bill on deficit reduction by Jan. 15 could indirectly affect pharmaceutical companies as providers exert pricing pressure.

Could PhRMA Be Headed To The Energy And Commerce Committee Hot Seat For Reform Law Compromises?

Committee Chairman Upton seeks details on closed door meetings between White House and outside parties in run-up to the passage of the health care reform bill, and letter to Deputy Chief of Staff DeParle suggests drug industry deals are among targets.

PhRMA May Find Staunch Health Reform Opponent, But Part D Friend, In Ways And Means Chair

House Ways and Means Committee Ranking Minority Member Dave Camp, R-Mich., appears poised to move to the chairman spot now that Republicans have taken control of the House.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS072623

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel